- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03772444
Use of Beetroot Juice to Protect Against Postoperative Ileus (POI) Following Colorectal Surgery: a Pilot Study. (BEET IT)
January 18, 2023 updated by: University Hospital, Ghent
The BEET IT study investigates the possible protective effect of beetroot juice on POI following colorectal surgery in (partially) blinded single-center phase 2 randomized trial (pilot study).
Study Overview
Status
Terminated
Conditions
Detailed Description
Postoperative ileus (POI) is a transient impairment of gastrointestinal motility following abdominal surgery, which leads to increased morbidity, prolonged hospitalization and increased healthcare cost.
The pathogenesis of POI involves inflammation and oxidative stress, similar to ischemia/reperfusion injury that can be counteracted with beetroot juice.
Beetroot juice is a source of inorganic nitrate, which by conversion of nitrate to nitrite in the body, exerts its protective effect.
We before demonstrated in a preclinical model that administration of exogenous nitrite was shown to protect against POI.
The aim of this pilot study is to investigate the possible protective effect of beetroot juice ingestion on POI following colorectal surgery.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Wim Ceelen
- Phone Number: +32(0)93326251
- Email: wim.ceelen@ugent.be
Study Contact Backup
- Name: Sarah Cosyns
- Phone Number: +32(0)93321562
- Email: sarah.cosyns@ugent.be
Study Locations
-
-
-
Gent, Belgium, 9000
- Ghent University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 95 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
• All patients undergoing colonic or upper rectum laparoscopic surgery.
Exclusion Criteria:
- Pregnancy or breast feeding
- Psychiatric pathology capable of affecting comprehension and judgment faculty
- History of metastatic disease
- History of prior abdominal bowel surgery
- Abdominal radiation treatment
- Chronic constipation (defined as two or fewer bowel movements per week)
- Gut motility influencing agents (e.g. tricyclic antidepressants, chronic use of laxatives)
- Frequent use of mouthwash, as this affects the enterosalivary circulation of nitrate
- Current use of broad-spectrum antibiotics, which will affect the oral flora and likely affect the nitrate reductase activity
- More than one bowel anastomosis during this surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Beetroot juice
|
Patients will drink 70 ml of beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
Placebo Comparator: Control group 1
|
Patients will drink 70 ml of nitrate-depleted beetroot juice daily in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
Sham Comparator: Control group 2
|
Patients will drink 70 ml of water in the week prior to surgery; the last dose will be administered via the nasogastric tube just before the start of the procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time until recovery of gastrointestinal function.
Time Frame: up to 30 days after surgery
|
Recovery of gastrointestinal function is defined as the interval (in days) from the end of surgery until passage of stool AND tolerance of solid food.
|
up to 30 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time until passage of stool, flatus or until tolerance of (semi-)solid oral diet (in days).
Time Frame: up to 30 days after surgery
|
up to 30 days after surgery
|
|
Overall post-operative complication rate defined according to the Clavien-Dindo Classification.
Time Frame: 3 months postoperatively
|
3 months postoperatively
|
|
Presence of prolonged postoperative ileus.
Time Frame: up to 30 days after surgery
|
Prolonged postoperative ileus is defined as presence of 2 or more of the following criteria on or after day 4 postoperatively: nausea or vomiting, inability to tolerate a solid or semi-solid oral diet, abdominal distension, absence of flatus and stool, radiological evidence of ileus.
|
up to 30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2018
Primary Completion (Actual)
May 25, 2019
Study Completion (Actual)
May 25, 2019
Study Registration Dates
First Submitted
December 5, 2018
First Submitted That Met QC Criteria
December 10, 2018
First Posted (Actual)
December 11, 2018
Study Record Updates
Last Update Posted (Actual)
January 20, 2023
Last Update Submitted That Met QC Criteria
January 18, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EC/2017/1476
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Ileus
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenRecruitingPostoperative IleusBelgium
-
West China HospitalCompletedPostoperative IleusChina
-
Hadassah Medical OrganizationCompleted
-
li xiongUnknown
-
Jinling Hospital, ChinaCompletedPostoperative IleusChina
-
Services Hospital, LahoreCompletedPostoperative IleusPakistan
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedPostoperative IleusBelgium
-
Gabriele Baldini, MD, MSc, Assistant ProfessorCompleted
-
Benazir Bhutto Hospital, RawalpindiCompletedPostoperative Ileus.Pakistan
Clinical Trials on Beetroot juice
-
Universidad Francisco de VitoriaUniversity of Alcala; University of SevilleCompleted
-
Bangor UniversityCompleted
-
University of ManchesterCompleted
-
Queen Mary University of LondonCompleted
-
University of Colorado, BoulderRecruitingChronic Kidney DiseaseUnited States
-
Penn State UniversityActive, not recruitingMetabolic SyndromeUnited States
-
Wake Forest University Health SciencesCompletedStroke | Ischemic Stroke | Cerebrovascular AccidentUnited States
-
University of ReadingSaudi Cultural BureauCompletedNo Dental Disease | Non-smokingUnited Kingdom
-
Bournemouth UniversityInstitute of Bioengineering and Bioimaging (IBB); University of Portsmouth; Loughborough...Completed
-
Universidad Autonoma de MadridUniversidad Politecnica de Madrid; Camilo Jose Cela UniversityCompletedNitrates | Nutrition | Physical Performance | Sport Physiology | Elite Athletes